AKBA · Akebia Therapeutics, Inc.
$0.87
+0.00 (+0.37%)
At close · Aug 14
Market Cap
$241.86M
Shares
277.11M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 4,481,610 | 12,370,962 | 16,852,572 | 61.3% |
| 2026-06-29 | 3,454,501 | 7,401,989 | 10,856,490 | 52.3% |
| 2026-06-22 | 2,861,384 | 9,798,611 | 12,659,995 | 48.1% |
| 2026-06-15 | 2,786,968 | 19,072,462 | 21,859,430 | 53.9% |
| 2026-06-08 | 4,760,536 | 19,103,013 | 23,863,549 | 70.8% |
| 2026-06-01 | 3,159,248 | 8,652,100 | 11,811,348 | 62.9% |
| 2026-05-25 | 3,065,426 | 3,934,859 | 7,000,285 | 61.6% |
| 2026-05-18 | 7,947,011 | 24,367,741 | 32,314,752 | 66.2% |
| 2026-05-11 | 3,510,172 | 8,226,033 | 11,736,205 | 50.8% |
| 2026-05-04 | 3,194,524 | 11,608,405 | 14,802,929 | 57.4% |
| 2026-04-27 | 1,323,938 | 4,557,300 | 5,881,238 | 57.2% |
| 2026-04-20 | 1,283,039 | 3,740,543 | 5,023,582 | 51.0% |
| 2026-04-13 | 1,997,545 | 6,522,574 | 8,520,119 | 55.2% |
| 2026-04-06 | 1,809,241 | 3,890,333 | 5,699,574 | 53.9% |
| 2026-03-30 | 1,150,017 | 2,280,340 | 3,430,357 | 41.5% |
| 2026-03-23 | 1,681,334 | 3,495,756 | 5,177,090 | 48.4% |
| 2026-03-16 | 2,397,952 | 5,355,134 | 7,753,086 | 41.6% |
| 2026-03-09 | 2,115,185 | 4,461,036 | 6,576,221 | 46.4% |
| 2026-03-02 | 2,382,874 | 4,515,948 | 6,898,822 | 49.0% |
| 2026-02-23 | 2,231,891 | 7,339,196 | 9,571,087 | 48.1% |
| 2026-02-16 | 1,889,378 | 5,073,617 | 6,962,995 | 61.7% |
| 2026-02-09 | 5,467,984 | 11,278,264 | 16,746,248 | 59.0% |
| 2026-02-02 | 2,565,190 | 4,113,763 | 6,678,953 | 42.1% |
| 2026-01-26 | 2,245,340 | 4,169,485 | 6,414,825 | 51.8% |
| 2026-01-19 | 1,915,261 | 4,324,112 | 6,239,373 | 56.1% |
| 2026-01-12 | 2,214,745 | 9,288,281 | 11,503,026 | 58.1% |
| 2026-01-05 | 1,768,541 | 4,556,460 | 6,325,001 | 45.3% |
| 2025-12-29 | 1,236,615 | 4,409,221 | 5,645,836 | 51.9% |
| 2025-12-22 | 1,422,318 | 3,047,597 | 4,469,915 | 48.1% |
| 2025-12-15 | 1,426,158 | 5,259,271 | 6,685,429 | 42.6% |
| 2025-12-08 | 2,020,281 | 6,870,583 | 8,890,864 | 55.5% |
| 2025-12-01 | 2,493,032 | 5,897,040 | 8,390,072 | 44.3% |
| 2025-11-24 | 1,711,568 | 2,432,100 | 4,143,668 | 46.2% |
| 2025-11-17 | 3,155,267 | 7,938,211 | 11,093,478 | 48.4% |
| 2025-11-10 | 5,362,754 | 19,127,431 | 24,490,185 | 55.9% |
| 2025-11-03 | 2,482,387 | 8,955,831 | 11,438,218 | 53.5% |
| 2025-10-27 | 8,136,025 | 20,356,125 | 28,492,150 | 56.7% |
| 2025-10-20 | 1,685,266 | 4,156,861 | 5,842,127 | 47.7% |
| 2025-10-13 | 1,673,147 | 4,521,457 | 6,194,604 | 50.9% |
| 2025-10-06 | 1,814,894 | 4,385,665 | 6,200,559 | 40.7% |
| 2025-09-29 | 1,867,369 | 3,786,572 | 5,653,941 | 49.4% |
| 2025-09-22 | 1,589,360 | 3,772,440 | 5,361,800 | 50.7% |
| 2025-09-15 | 2,280,300 | 6,372,524 | 8,652,824 | 37.4% |
| 2025-09-08 | 3,293,222 | 5,626,509 | 8,919,731 | 54.0% |
| 2025-09-01 | 3,526,505 | 5,978,796 | 9,505,301 | 48.2% |
| 2025-08-25 | 3,185,239 | 5,207,372 | 8,392,611 | 42.1% |
| 2025-08-18 | 3,281,996 | 5,722,280 | 9,004,276 | 48.4% |
Showing 1–47 of 47 weeks
Key facts
CIK
1517022
CUSIP
00972D105
13F (30d)
161 filings
161 filers
Visit website
Investor relations